EGFR and nasopharyngeal carcinoma: This study demonstrated that this interaction increases the dimerization and phosphorylation of EGFR, which enhances the activation of JAK2‐STAT3 signaling pathway, contributing to increasement of cisplatin resistance in NPC cells.